跳至主要内容
临床试验/IRCT20170609034406N2
IRCT20170609034406N2已完成未知

Effects of omega-3 fatty acids on uremic pruritus in chronic hemodialysis patients

Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years ;
  • Beginning hemodialysis for at least 3 months and three times per week ;
  • Ability to understand and sign consent form ;
  • Use of biocompatible dialysis membrane.
  • Properly functioning arteriovenous fistula or catheter function;
  • Dialysis adequacy above 1.2.

排除标准

  • Exclusion criteria : Other causes of itching, except kidney failure ;
  • Pregnancy ;
  • The presence of any chronic, active, uncontrolled or severe chronic inflammatory disease (autoimmune diseases, connective tissue disease, malignancy, HIV, liver disease and pulmonary disease) ;
  • presence of chronic infection or acute infection in the last month ;
  • Hemoglobin less than 10 g / dL ;
  • Co-presence in another trial ;
  • Medical history (such as heart attack ) or surgical in the last 3 months ;
  • Symptoms of malabsorption ;
  • Bleeding disorders ( Includes coagulopathies) or high risk of bleeding ;
  • Change in diet in the last 1 month;
  • Consumption of Omega-3 or any supplement containing omega-3 in the last 3 months. ;
  • Intolerance or susceptibility to drug ;
  • Receiving drugs that have an effect on inflammatory factors (corticosteroids or other immunosuppressive drugs, non-steroidal anti-inflammatory drugs, contraceptives, pentoxifylline) in the last 6 weeks;
  • Concomitant use of methyl dopa, cimetidine and serotonergic drugs such as triptans, tramadol, tryptophan and linzolide ;
  • Use of warfarin ;
  • Abuse of alcohol and other substances that cause dependence.

研究者

相似试验